Expiration date: 06/2026

Release form, composition and packing

Lozenges flat cylindrical shape, with a chamfered and Valium, from white to almost white color. On the flat side with the mark applied inscription MATERIA MEDICA, on the other flat side coated DIVAZA inscription.

One tablet contains:

antibodies to brain-specific proteins S-100 0.006 g *

antibodies to endothelial NO synthase 0.006 g *

* Applied to the lactose in a mixture of three aqueous-alcoholic active substance dilutions diluted respectively at 10012, 10030, 100200 times.

Excipients: lactose monohydrate, microcrystalline cellulose, magnesium stearate.

Clinico-pharmacological group: nootropics

Pharmaco-therapeutic group: nootropics

Testimony

• The restoration of the integrative activity of the brain in a wide range of organic CNS disorders, including those caused by neurodegenerative diseases, cerebrovascular (including ischemic) diseases neuroinfections, traumatic brain injury - in the complex therapy,
  
• Monotherapy somatoform dysfunction of the autonomic nervous system.
  

Dosage

Inside. At one time - 1 tablet (kept in the mouth until complete dissolution). Apply 1-2 tablets 3 times a day is receiving write. Depending on the severity of the condition during the acute phase of reception frequency can be increased to 4-6 times per day.

When expressed organic CNS lesions duration of the course of therapy can be up to 4-6 months.

Side effect

Possible reactions of individual hypersensitivity to the drug.

Contraindications

• Increased individual sensitivity to the drug,
  
• Before the age of 18 years due to lack of efficacy and safety data for this age group.
  

Pregnancy and breast-feeding

Safety of Divazy during pregnancy and lactation has not been studied. If necessary, the appointment should take into account the risk / benefit ratio.

Use in children

It is contraindicated in children under 18 years.

Special instructions

The product contains lactose, and therefore it is not recommended for patients with congenital galactosemia, malabsorption of glucose or galactose, or congenital lactase deficiency.

Effects on ability to drive vehicles and management mechanisms

Divaza does not affect the ability to drive vehicles and other potentially dangerous machinery.

Overdose

In case of accidental overdose possible dyspeptic symptoms caused by members of the excipients of the drug.

Drug interactions

Incompatibilities with other drugs has not yet been registered.